Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality.
By Yadong Cui, R. Blumenthal, J. Flaws, M. Whiteman, P. Langenberg, P. Bachorik, T. Bush. Archives of Internal Medicine, 2001
684 citations recorded by the source corpus.
Subfields: Biochemistry, Endocrinology, Diabetes and Metabolism, Surgery
View Paper: https://www.semanticscholar.org/paper/b3a4f5585f6eead32b0fe8d08f5dd837b85cd003
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Endocrinology, Diabetes and Metabolism
In Surgery
Citations in the corpus
- National lipid association recommendations for patient-centered management of dyslipidemia: part 1--full report. (2015, background): “When triglycerides are between 200 and 499 mg/dL, the targets of therapy are non–HDL-C and LDL-C.”
- Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group. (2003, neutral): “Non– HDL-C is an independent predictor of cardiovascular events [80, 81].”